MedTrace Logo

Molecular Profiling of Advanced Biliary Tract Cancers

NCT03419247 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-04-01

No results posted yet for this study

Summary

This is a study where fresh tumor tissue and blood samples will be collected from patients with advanced biliary tract cancer who will be undergoing 1st line therapy with gemcitabine or fluorouracil (5-FU) regimens to see how useful it is to look for changes and characteristics in genes (molecules that contain instructions for the development and functioning of the cells) and the genes within the tumour to find characteristics that may be useful in choosing treatments for patients in the future.

Conditions

  • Biliary Tract Cancer

Interventions

PROCEDURE

Fresh tumor tissue biopsy

A type of surgical procedure that will use a thin needle to remove a sample of tumor tissue.

PROCEDURE

Blood draw

Blood will be taken by a needle from a vein.

PROCEDURE

Archival tumor tissue collection

A sample of tumor tissue that was taken by biopsy or surgery before agreeing to take part in this study will be collected.

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Jennifer J Knox, M.D. · Princess Margaret Cancer Centre

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-01-02
Completion
2023-01-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03419247 on ClinicalTrials.gov